Both prognostic genes appear to be expressed in the stroma, with upregulation of TAGLN in gastric stromal carcinoma-associated fibroblasts (40), and increased expression of THBS2 implicated in tumor progression and poor prognosis in pancreatic cancer, excreted by stromal fibroblasts (41). The gene discussed is THBS2; the disease is pancreatic neoplasm.